Search
for
Sort by
Research 241–270 of 691
- Alternative Medicine for Hair Loss
- British Hair and Nail Society
- Aging Skin: A Window to the Body
- The Skin and Subcutaneous Tissues
- Psikonöroimmünoloji ve Multifaktöryel Psikodermatolojik Hastalıklar
- Primary cicatricial alopecias
- Cutaneous drug reactions
- Skin Diseases in Pregnancy
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Skin aging: mechanisms, evaluation, and rejuvenation
- Spectrum and clinical burden of Unrecognized Dermatologic Diseases in hospitalized adults: A single-centre cross-sectional study
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Prevalence and Clinical Spectrum of Dermatologic Conditions in Renal Transplant Recipients: A 10-Year Retrospective Cross-Sectional Study
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- A cross sectional study on geriatric dermatosis in patients attending a tertiary care hospital
- Geriatric Dermatologic Therapy
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Coexistence of alopecia areata and fixed drug eruption: An uncommon isotopic phenomenon?
- A Cross-Sectional Analysis of Psychological and Dermatologic Manifestations Post-February 6 Earthquakes in Dermatology Patients
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches